A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma.

Sheng YuLingxue TangQianqian ZhangWen LiSenbang YaoYinlian CaiHuai-Dong Cheng

Published in: Hereditas (2023)

Based on cuproptosis-related lncRNAs, we constructed and validated a novel risk signature that may be used to predict immunotherapy efficacy and prognosis in LUAD patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
long non coding rna
genome wide analysis